SYNPO2 and prostate cancer: A new SYNPO2 transcript lacking the N terminus was found to promote prostate cancer cell invasion by activating RHO-ROCK signaling, indicating that abnormal SYNPO2 can initiate YAP1 nuclear translocation as well as transcriptional activity and promote cancer progression [48] (Fig. 3).